Arden Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,359
Closed -$728K 383
2018
Q4
$728K Sell
11,359
-287
-2% -$21.2K 0.13% 161
2018
Q3
$1.04M Sell
11,646
-600
-5% -$53K 0.16% 134
2018
Q2
$973K Sell
12,246
-346
-3% -$28.7K 0.15% 140
2018
Q1
$1.12M Sell
12,592
-323
-3% -$31K 0.17% 130
2017
Q4
$1.35M Buy
12,915
+1,187
+10% +$134K 0.2% 101
2017
Q3
$1.71M Sell
11,728
-527
-4% -$71.8K 0.26% 83
2017
Q2
$1.59M Sell
12,255
-194
-2% -$23.8K 0.24% 85
2017
Q1
$1.55M Sell
12,449
-4,382
-26% -$524K 0.24% 84
2016
Q4
$1.95M Sell
16,831
-659
-4% -$73.4K 0.3% 70
2016
Q3
$1.83M Sell
17,490
-24,828
-59% -$2.69M 0.28% 71
2016
Q2
$4.17K Buy
42,318
+1,316
+3% +$136K 0.31% 79
2016
Q1
$4.1M Buy
41,002
+104
+0.3% +$10.7K 0.33% 77
2015
Q4
$4.9M Buy
40,898
+443
+1% +$51.3K 0.41% 60
2015
Q3
$4.38M Buy
40,455
+12,469
+45% +$1.55M 0.36% 71
2015
Q2
$3.24K Sell
27,986
-691
-2% -$79K 0.48% 51
2015
Q1
$3.31K Buy
28,677
+5,113
+22% +$611K 0.48% 50
2014
Q4
$2.63M Sell
23,564
-2,753
-10% -$290K 0.36% 56
2014
Q3
$2.5M Sell
26,317
-3,111
-11% -$281K 0.34% 58
2014
Q2
$2.53M Sell
29,428
-610
-2% -$46.4K 0.34% 60
2014
Q1
$2.1M Sell
30,038
-3,414
-10% -$270K 0.26% 76
2013
Q4
$2.83M Sell
33,452
-2,228
-6% -$176K 0.34% 55
2013
Q3
$2.75M Sell
35,680
-29,028
-45% -$2.03M 0.35% 49
2013
Q2
$3.79M Buy
+64,708
New +$3.89M 0.46% 37

Other funds holding CELG

Arden Trust's CELG Position: Q1 2019 in Review

Arden Trust sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 11,359 shares — an estimated $728K sold.

Arden Trust first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $4.9M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Arden Trust reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Arden Trust sold 11,359 Celgene Corp shares in Q1 2019, an estimated $728K.
  • Arden Trust first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Arden Trust's Celgene Corp position peaked at $4.9M in Q4 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Arden Trust's 13F filing for Q1 2019, filed 26 Apr 2019.